Cancer medicines

Enzalutamide

Enzalutamide

An oral therapy blocking androgen receptor signaling.

Sources checked · Introductory guide

On this page

How it works

It inhibits androgen receptors to limit prostate cancer growth.[3]

Where it is used

Used in selected metastatic, castration-resistant or high-risk biochemical recurrent prostate cancers. Check the endocrine combination for your setting.[1]

Key safety points

Discuss falls, fatigue and drug interactions. Seizures, altered consciousness, chest pain or breathlessness need immediate care.[2]

Questions for your care team

  • Do I continue hormone injections, and how are fall and seizure risks assessed?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Enzalutamide (opens in a new tab)
  2. MedlinePlus · Enzalutamide (opens in a new tab)
  3. NCI Drug Dictionary · Enzalutamide (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

Enzalutamide | Cancer Encyclopedia | My Chemo Diary